Federation of American Scientists Case Studies in Dual Use Biological Research Module 5.0: Antibiotic Resistance Case Study
Topic: Discussion Subtopic: Discussion Questions

Should biological companies be required to screen their orders to ensure that they are going to reputable universities, institutes, or investigators?

How can tools like RNAi be handled so that their potential for misuse is minimized, but are still widely available to legitimate researchers?

What do you think of Dr. Hannon’s views on biosecurity and biosafety?

Do you think that RNAi poses a serious biosecurity threat?


Many scientists who work with RNAi do not consider it a dual-use technology. Do you think that this attitude should be changed and if so, how can it be changed?


Back Next
Topic History of RNAi Genetic Control in Mice Implications Discussion References Home